What's new

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Mar 17, 2025 - 13:42
 0
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Read More

Tags:

Previous Article

Workshop managers share concerns over potential MOT recall rule change

Next Article

Health Canada approves RetinaLogik’s VR visual exam platform

Related Posts

Human medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

EMEA-003043-PIP01-21-M01

EMEA-003043-PIP01-21-M01

Mar 12, 2025  0

PSUSA/00003148/202405

PSUSA/00003148/202405

Feb 9, 2025  0